Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The antithrombotic effects of heparin have led to its use as a flush
solution for peripheral intravascular infusion devices. On p 969
Randolph et al report a systematic review of the benefit of heparin in
peripheral venous and arterial catheters. Current evidence supports
discontinuing the practice of flushing peripheral venous catheters that
are locked between use with 10 U/ml of heparin solution. However,
heparin significantly prolongs the duration of peripheral arterial
catheter patency and decreases the risk of clots. In peripheral venous
catheters heparin added to the infusion at 1 U/ml decreases phlebitis
and may decrease infusion failure.